• tags:AAOphthalmology
Alcon debuts rebranded DSLT device and surgical products
Products

Alcon debuts rebranded DSLT device and surgical products

Company offers a sneak peek of its newly-named Voyager DSLT and two gas delivery system systems for retinal detachments—plus clinical updates on a new DED treatment.
Zeiss showcases expanded ophthalmic portfolio of digital tools
Products

Zeiss showcases expanded ophthalmic portfolio of digital tools

Company introduces new AI-based software solutions and highlights technologies from its Cataract and Retina Workflows as well as two new microscopes.
Beyeonics launches Beyeonics One ophthalmic exoscope with invisible light
Products

Beyeonics launches Beyeonics One ophthalmic exoscope with invisible light

First fully digital microscope of its kind includes an augmented reality-based headset and invisible infrared illumination.
Beacon Therapeutics reports positive 24-month phase 2 XLRP gene therapy data
Pipeline

Beacon Therapeutics reports positive 24-month phase 2 XLRP gene therapy data

Latest findings demonstrate AGTC-501 to be generally safe and well-tolerated, with a 57% response rate noted among high-dose-treated eyes. 
AAO, NANOS respond to study on semaglutide-NAION connection
Research

AAO, NANOS respond to study on semaglutide-NAION connection

Recent research identified substantial risk for NAION development among diabetic and obese patients using the GLP-1 RA.
AAO validates teleretinal screening for effective DR detection
Research

AAO validates teleretinal screening for effective DR detection

Teleretinal screening shown to be an accurate and cost-effective approach to DR screening.
Eye color-changing surgeries spark AAO warning
Research

Eye color-changing surgeries spark AAO warning

Academy alerts consumers of potential risks associated with iris implant surgery and keratopigmentation. 
Lumenis launches OptiPLUS radio frequency device for DED
Products

Lumenis launches OptiPLUS radio frequency device for DED

The first dual frequency radio frequency device is designed as a complement to the novel OptiLIGHT technology.
Alcon's SmartCataract cloud-based app now commercially available
Products

Alcon's SmartCataract cloud-based app now commercially available

Platform is the first and only device of its kind, integratable with any phaco system.
Exhibit hall highlights from AAO: Day 3
Events

Exhibit hall highlights from AAO: Day 3

Michael Ammar, MD,  shares his final takeaways from the Expo floor at AAO.
Revisiting ocular antibiotic resistance with the ARMOR study
Research

Revisiting ocular antibiotic resistance with the ARMOR study

Updated findings explore the methicillin resistance of endophthalmitis isolates against common antibiotics.
Focusing in: Surgical innovation highlights at AAO
Pipeline

Focusing in: Surgical innovation highlights at AAO

Eric Donnenfeld, MD, FAAO, FACS, shares clinical updates on two innovative technologies and his pick for a must-attend session.
Zeiss launches PROSPARA cloud-based software solution
Products

Zeiss launches PROSPARA cloud-based software solution

Company is introducing a broad range of digital tools and updates at AAO 2023.
Positive 1-year data reported in ALTITUDE gene therapy trial
Pipeline

Positive 1-year data reported in ALTITUDE gene therapy trial

Ongoing phase 2 trial reports potential for one-time injection in managing DR.
Pediatric sickle cell disease study reports surprising ophthalmic findings
Research

Pediatric sickle cell disease study reports surprising ophthalmic findings

Largest retrospective review of sickle cell disease patients uncovers critical need for regular screenings.
Clinical perspective from AAO: Day 2
Research

Clinical perspective from AAO: Day 2

Michael Ammar, MD, offers a clinical look at the day’s top sessions and key research, including big news from two FDA-approved treatments.
Two-year data reported for GATHER2 study on Izervay
Products

Two-year data reported for GATHER2 study on Izervay

Phase 3 study results indicate a continued reduction in GA lesion growth.
Three-year data supports extended treatment of Syfovre for GA
Research

Three-year data supports extended treatment of Syfovre for GA

Phase 3 GALE study results indicate a continued reduction in GA lesion growth.
Centricity Vision launches ZEPTOLink IOL Positioning System
Products

Centricity Vision launches ZEPTOLink IOL Positioning System

Platform is the first and only device of its kind, integratable with any phaco system.
Topcon Healthcare introduces TEMPO Perimeter
Products

Topcon Healthcare introduces TEMPO Perimeter

Perimeter incorporates a binocular approach, demonstrating a performance 39% faster than SAP.